IR-Med (IRME) Return on Equity (2021 - 2025)

IR-Med's Return on Equity history runs 5 years deep, the most recent figure standing at 0.03% for Q2 2025.

• In Q2 2025, Return on Equity rose 28.0% year-over-year to 0.03%; the TTM figure through Jun 2025 stood at 0.03% (up 28.0% YoY), while the FY2024 annual figure was 0.55%, down 51.0% from the prior year.
• Return on Equity came in at 0.03% for Q2 2025 at IR-Med, down from 0.04% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.13% in Q4 2024 to a low of 0.3% in Q1 2024.
• A 5-year average of 0.05% and a median of 0.02% in 2021 frame the typical range for Return on Equity.
• Across the five-year window, Return on Equity dropped 28 bps in 2024 and jumped 34 bps in 2025, its largest moves.
• IR-Med's Return on Equity stood at 0.02% in 2021, then soared by 31 bps to 0.02% in 2022, then tumbled by 303 bps to 0.06% in 2023, then jumped by 313 bps to 0.13% in 2024, then plunged by 80 bps to 0.03% in 2025.
• According to Business Quant data, Return on Equity over the past three periods registered 0.03%, 0.04%, and 0.13% for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison